These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15999186)

  • 21. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
    Hou T; Zhang W; Case DA; Wang W
    J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A chemical genetic method for generating bivalent inhibitors of protein kinases.
    Hill ZB; Perera BG; Maly DJ
    J Am Chem Soc; 2009 May; 131(19):6686-8. PubMed ID: 19391594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SH3 domain protein-binding arrays.
    Chamnongpol S; Li X
    Methods Mol Biol; 2004; 264():183-9. PubMed ID: 15020790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
    Liu J; Li M; Ran X; Fan JS; Song J
    Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biologically relevant targets and binding affinity requirements for the function of the yeast actin-binding protein 1 Src-homology 3 domain vary with genetic context.
    Haynes J; Garcia B; Stollar EJ; Rath A; Andrews BJ; Davidson AR
    Genetics; 2007 May; 176(1):193-208. PubMed ID: 17409071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity.
    Solheim SA; Petsalaki E; Stokka AJ; Russell RB; Taskén K; Berge T
    FEBS J; 2008 Oct; 275(19):4863-74. PubMed ID: 18721137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
    McDonald CB; Seldeen KL; Deegan BJ; Farooq A
    Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis of PxxDY motif recognition in SH3 binding.
    Aitio O; Hellman M; Kesti T; Kleino I; Samuilova O; Pääkkönen K; Tossavainen H; Saksela K; Permi P
    J Mol Biol; 2008 Sep; 382(1):167-78. PubMed ID: 18644376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystallization by capillary counter-diffusion and structure determination of the N114A mutant of the SH3 domain of Abl tyrosine kinase complexed with a high-affinity peptide ligand.
    Cámara-Artigas A; Palencia A; Martínez JC; Luque I; Gavira JA; García-Ruiz JM
    Acta Crystallogr D Biol Crystallogr; 2007 May; 63(Pt 5):646-52. PubMed ID: 17452790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial unfolding of diverse SH3 domains on a wide timescale.
    Wales TE; Engen JR
    J Mol Biol; 2006 Apr; 357(5):1592-604. PubMed ID: 16487539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition of non-canonical peptides by the yeast Fus1p SH3 domain: elucidation of a common mechanism for diverse SH3 domain specificities.
    Kim J; Lee CD; Rath A; Davidson AR
    J Mol Biol; 2008 Mar; 377(3):889-901. PubMed ID: 18280496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A proline to glycine mutation in the Lck SH3-domain affects conformational sampling and increases ligand binding affinity.
    Bauer F; Sticht H
    FEBS Lett; 2007 Apr; 581(8):1555-60. PubMed ID: 17382937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.
    Wu C; Ma MH; Brown KR; Geisler M; Li L; Tzeng E; Jia CY; Jurisica I; Li SS
    Proteomics; 2007 Jun; 7(11):1775-85. PubMed ID: 17474147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
    Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
    Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of solvation sites at the interface of Src SH2 domain complexes using molecular dynamics simulations.
    Geroult S; Hooda M; Virdee S; Waksman G
    Chem Biol Drug Des; 2007 Aug; 70(2):87-99. PubMed ID: 17683370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of protein-ligand interactions by photocleavage of a cyclic peptide using phosphatidylinositol 3-kinase SH3 domain as model system.
    Takahashi I; Kuroiwa S; Lindfors HE; Ndamba LA; Hiruma Y; Yajima T; Okishio N; Ubbink M; Hirota S
    J Pept Sci; 2009 Jun; 15(6):411-6. PubMed ID: 19378350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The high-resolution NMR structure of a single-chain chimeric protein mimicking a SH3-peptide complex.
    Candel AM; Conejero-Lara F; Martinez JC; van Nuland NA; Bruix M
    FEBS Lett; 2007 Feb; 581(4):687-92. PubMed ID: 17275816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor analysis scales of generalized amino acid information as applied in predicting interactions between the human amphiphysin-1 SH3 domains and their peptide ligands.
    Liang G; Chen G; Niu W; Li Z
    Chem Biol Drug Des; 2008 Apr; 71(4):345-51. PubMed ID: 18318694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase.
    Abouzid K; Shouman S
    Bioorg Med Chem; 2008 Aug; 16(16):7543-51. PubMed ID: 18678492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High resolution crystal structures of the p120 RasGAP SH3 domain.
    Ross B; Kristensen O; Favre D; Walicki J; Kastrup JS; Widmann C; Gajhede M
    Biochem Biophys Res Commun; 2007 Feb; 353(2):463-8. PubMed ID: 17188236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.